NCT02674152View on ClinicalTrials.gov

Dose Finding Study of BI 836880 in Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

January 5, 2016

Primary Completion Date

September 12, 2018

Study Completion Date

November 4, 2020

Conditions
Neoplasms
Interventions
DRUG

BI 836880

BI 836880

Trial Locations (3)

75248

INS Curie, Paris

79106

Universitätsklinikum Freiburg, Freiburg im Breisgau

86156

Universitätsklinikum Augsburg, Augsburg

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY